Jiajia Gu

606 total citations
20 papers, 435 citations indexed

About

Jiajia Gu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jiajia Gu has authored 20 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Jiajia Gu's work include MicroRNA in disease regulation (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Cancer-related molecular mechanisms research (4 papers). Jiajia Gu is often cited by papers focused on MicroRNA in disease regulation (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Cancer-related molecular mechanisms research (4 papers). Jiajia Gu collaborates with scholars based in China, United States and Nigeria. Jiajia Gu's co-authors include Xia He, Li Yin, Taofeek K. Owonikoko, Guojing Zhang, Shi‐Yong Sun, Jing Wu, Mingyu Du, Suresh S. Ramalingam, Luxi Qian and Dan Zong and has published in prestigious journals such as PLoS ONE, Cancer and Cancer Research.

In The Last Decade

Jiajia Gu

19 papers receiving 431 citations

Peers

Countries citing papers authored by Jiajia Gu

Since Specialization

Citations

This map shows the geographic impact of Jiajia Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiajia Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiajia Gu more than expected).

Fields of papers citing papers by Jiajia Gu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiajia Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiajia Gu. The network helps show where Jiajia Gu may publish in the future.

Co-authorship network of co-authors of Jiajia Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiajia Gu. A scholar is included among the top collaborators of Jiajia Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiajia Gu. Jiajia Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pseudoprogression in the era of immunotherapy-based strategies for recurrent head and neck squamous cell carcinoma achieving complete response: A case report 2023 ·Medicine ·Jiawei Zhou, (unknown), Jiajia Gu, Jingyuan Zhang, Dayong Gu, Xiuming Zhang, (unknown), Xia He, Lirong Wu	0
2	Depletion of SOD2 enhances nasopharyngeal carcinoma cell radiosensitivity via ferroptosis induction modulated by DHODH inhibition 2023 ·BMC Cancer ·(unknown), Ning Jiang, Dan Zong, Jiajia Gu, Jiawei Zhou, Yin Li, Xia He, Yong Xu, Lirong Wu	31
3	Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation EGFR Tyrosine Kinase Inhibitor, Osimertinib 2021 ·Cancer Research ·Lei Zhu, Zhen Chen, Hongjing Zang, Songqing Fan, Jiajia Gu, Guojing Zhang, (unknown), Qiming Wang, Yong He, Taofeek K. Owonikoko, Suresh S. Ramalingam, Shi‐Yong Sun	50
4	BRD4 Levels Determine the Response of Human Lung Cancer Cells to BET Degraders That Potently Induce Apoptosis through Suppression of Mcl-1 2020 ·Cancer Research ·Dan Zong, Jiajia Gu, Giovanna C. Cavalcante, Weilong Yao, Guojing Zhang, Shaomeng Wang, Taofeek K. Owonikoko, Xia He, Shi‐Yong Sun	38
5	Inhibition of ACK1 delays and overcomes acquired resistance of EGFR mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib 2020 ·Lung Cancer ·Jiajia Gu, Luxi Qian, Guojing Zhang, Nupam P. Mahajan, Taofeek K. Owonikoko, Suresh S. Ramalingam, Shi-Yong Sun	18
6	The novel MET inhibitor, HQP8361, possesses single agent activity and enhances therapeutic efficacy of AZD9291 (osimertinib) against AZD9291-resistant NSCLC cells with activated MET. 2020 ·PubMed ·(unknown), Yiting Li, (unknown), Jiajia Gu, Zhen Chen, Taofeek K. Owonikoko, Suresh S. Ramalingam, Shi‐Yong Sun	8
7	MEK or ERK inhibition effectively abrogates emergence of acquired osimertinib resistance in the treatment of epidermal growth factor receptor–mutant lung cancers 2020 ·Cancer ·Jiajia Gu, Weilong Yao, Puyu Shi, Guojing Zhang, Taofeek K. Owonikoko, Suresh S. Ramalingam, Shi‐Yong Sun	35
8	Feedback loop in miR‐449b‐3p/ADAM17/NF‐κB promotes metastasis in nasopharyngeal carcinoma 2019 ·Cancer Medicine ·Qian Fei, Mingyu Du, Luxi Qian, (unknown), Jie Chen, Hongming Zhu, Xiaokang Tian, Ning Jiang, Jiajia Gu, Xia He, Li Yin	9
9	Progress of preoperative and postoperative radiotherapy in gastric cancer 2018 ·World Journal of Surgical Oncology ·Nan Zhang, Qian Fei, Jiajia Gu, Li Yin, Xia He	24
10	MiR-152 functioning as a tumor suppressor that interacts with DNMT1 in nasopharyngeal carcinoma 2018 ·OncoTargets and Therapy ·Zhiwei Lü, Mingyu Du, Luxi Qian, Nan Zhang, Jiajia Gu, Kai Ding, Jing Wu, Hongming Zhu, Xia He, Yin Li	15
11	TGF-β regulates the ERK/MAPK pathway independent of the SMAD pathway by repressing miRNA-124 to increase MALAT1 expression in nasopharyngeal carcinoma 2018 ·Biomedicine & Pharmacotherapy ·Mingyu Du, Wei Chen, Wenjun Zhang, Xiaokang Tian, Tingting Wang, Jing Wu, Jiajia Gu, Nan Zhang, Zhiwei Lü, Luxi Qian, Qian Fei, Yan Wang, (unknown), Xia He, Li Yin	28
12	MIIP gene expression is associated with radiosensitivity in human nasopharyngeal carcinoma cells 2018 ·Oncology Letters ·(unknown), Luxi Qian, Nan Zhang, Jiajia Gu, Kai Ding, Jing Wu, Zhiwei Lü, Mingyu Du, Hongming Zhu, Jian Wu, Xia He, Li Yin	5
13	Long non-coding RNA n326322 promotes the proliferation and invasion in nasopharyngeal carcinoma 2017 ·Oncotarget ·Mingyu Du, Teng Huang, Jing Wu, Jiajia Gu, Nan Zhang, Kai Ding, Luxi Qian, Zhiwei Lü, Wenjun Zhang, Xiaokang Tian, Xia He, Li Yin	10
14	MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis 2016 ·Journal of Experimental & Clinical Cancer Research ·Teng Huang, Li Yin, Jing Wu, Jiajia Gu, Jian Wu, Dan Chen, Hongliang Yu, Kai Ding, Nan Zhang, Mingyu Du, Luxi Qian, Zhiwei Lü, Xia He	69
15	Cetuximab and Cisplatin Show Different Combination Effect in Nasopharyngeal Carcinoma Cells Lines via Inactivation of EGFR/AKT Signaling Pathway 2016 ·Biochemistry Research International ·Jiajia Gu, Li Yin, Jing Wu, Nan Zhang, Teng Huang, Kai Ding, Haixia Cao, Lin Xu, Xia He	15
16	Incorporation of alpha-fetoprotein(AFP) into subclassification of BCLC C stage hepatocellular carcinoma according to a 5-year survival analysis based on the SEER database 2016 ·Oncotarget ·Nan Zhang, Jiajia Gu, Yin Li, Jing Wu, Mingyu Du, Kai Ding, Teng Huang, (unknown)	15
17	MiR-145, a microRNA targeting ADAM17, inhibits the invasion and migration of nasopharyngeal carcinoma cells 2015 ·Experimental Cell Research ·Jing Wu, Li Yin, Ning Jiang, Wenjie Guo, Jiajia Gu, Meng Chen, Youyou Xia, Jian Wu, Dan Chen, Jianfeng Wu, Dejun Wang, Dan Zong, Nan Zhang, Kai Ding, Teng Huang, Xia He	26
18	Long-Term Results of Concurrent Chemoradiotherapy for Advanced N2-3 Stage Nasopharyngeal Carcinoma 2015 ·PLoS ONE ·Li Yin, Xiuhua Bian, Xue Wang, Meng Chen, Jing Wu, Jianhua Xu, (unknown), Wenjie Guo, Xuesong Jiang, (unknown), Jiajia Gu, Jianfeng Wu, Yewei Zhang, Xia He	6
19	Impact of Plasma Epstein-Barr Virus-DNA and Tumor Volume on Prognosis of Locally Advanced Nasopharyngeal Carcinoma 2015 ·BioMed Research International ·Meng Chen, Li Yin, Jing Wu, Jiajia Gu, Xuesong Jiang, Dejun Wang, Dan Zong, Chang Guo, (unknown), Jianfeng Wu, (unknown), Wenjie Guo	25
20	Radiosensitization Effect of Nedaplatin on Nasopharyngeal Carcinoma Cells in Different Status of Epstein-Barr Virus Infection 2014 ·BioMed Research International ·Li Yin, Jing Wu, Jianfeng Wu, Jinjun Ye, Xuesong Jiang, Meng Chen, Dejun Wang, Xue Wang, Dan Zong, Jiajia Gu, Junying Zhang, Jian Wu, Lin Xu, (unknown), Wenjie Guo	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact